SFT2D2 and neoplasm: The results indicated that SFT2D2‐TBX19 lncRNA contributed approximately 60–70% to tumor cell development, while TBX19‐202 accounted for about 30–40% (Figures 4A,B and S7C,D, Supporting Information).